Objective: To explore the trend of blood pressure among children and adolescents and its correlation with pubertal development and nutritional status, so as to provide a scientific basis for developing prevention strategies targeting early stage hypertension. Methods: In September 2023, a multi stage random cluster sampling was used to select 20 241 primary and secondary school students aged 7-18 years from 57 schools in Jinzhong, whose height, weight, and blood pressure were measured. The Chi square test for trend was used to analyze the change trend in the detection rate of elevated blood pressure and hypertension in children and adolescents with the development of adolescence puberty, and the Logistic regression was used to analyze the correlation between elevated blood pressure and hypertension and nutritional status. Results: The prevalence of elevated blood pressure was 17.3% among children and adolescents. The middle and late pubertal groups had the highest prevalence (23.2% and 24.3%), followed by the early pubertal group (19.5%) and the prepuberty group (10.8%) ( χ 2 trend =372.86， P <0.01). The prevalence of hypertension was 14.8%, with the highest prevalence reported in the late pubertal group (22.4%), followed by the middle pubertal group (18.9%), and the early pubertal (13.0%)/prepuberty (12.2%) groups ( χ 2 trend =175.43， P <0.01). The prevalence of elevated blood pressure and hypertension increased with pubertal development, regardless of gender, region, or nutritional status ( χ 2 trend =9.21-771.90, P <0.01). Overweight and obesity were influencing factors of elevated blood pressure and hypertension among children and adolescents during all stages of pubertal development ( OR =1.2-2.8， P <0.01). Conclusion The prevalence of elevated blood pressure and hypertension among children and adolescents during pubertal development is high, showing an increasing trend with pubertal development.

Diabetes mellitus is a global epidemic characterized by high incidence and mortality rates. It can lead to both acute and chronic systemic complications. Diabetes-induced male reproductive disorders have become a focal point of concern. Numerous studies have shown that hyperglycemia can impair male fertility through various pathways, including erectile and ejaculatory dysfunction, disruption of the hypothalamic-pituitary-gonadal axis, damage to the epididymis and testis, impaired semen quality, abnormalities in testicular and sperm glucose metabolism, and adverse effects on offspring health. The mechanisms involved include oxidative stress, inflammation, autophagy, apoptosis, epigenetic regulation, and mitochondrial damage. Interventions for male fertility impairment include diabetes treatment drugs, antioxidants, Traditional Chinese Medicine and acupuncture, mesenchymal stem cell therapy, exercise and physical training, as well as gut microbiota interventions. This article aims to review the current research on the relationship between diabetes and male fertility, explore the underlying mechanisms leading to male infertility, and identify potential interventions to improve male reproductive health, which holds significant clinical value.

Diabetes mellitus is a global epidemic characterized by high incidence and mortality rates. It can lead to both acute and chronic systemic complications. Diabetes-induced male reproductive disorders have become a focal point of concern. Numerous studies have shown that hyperglycemia can impair male fertility through various pathways, including erectile and ejaculatory dysfunction, disruption of the hypothalamic-pituitary-gonadal axis, damage to the epididymis and testis, impaired semen quality, abnormalities in testicular and sperm glucose metabolism, and adverse effects on offspring health. The mechanisms involved include oxidative stress, inflammation, autophagy, apoptosis, epigenetic regulation, and mitochondrial damage. Interventions for male fertility impairment include diabetes treatment drugs, antioxidants, Traditional Chinese Medicine and acupuncture, mesenchymal stem cell therapy, exercise and physical training, as well as gut microbiota interventions. This article aims to review the current research on the relationship between diabetes and male fertility, explore the underlying mechanisms leading to male infertility, and identify potential interventions to improve male reproductive health, which holds significant clinical value.

Objective To investigate the assessment methods and mechanisms of nonsteroidal antiinflammatory drugs (NSAID)-induced injury in rat small intestinal epithelial barrier,and to explore the protective effects of mucosal protective agents and antacids on it.Methods A total of 96 rats were evenly divided into the morphologic observation group and the mechanism research group,and 48 in each group.Then each group was evenly divided into eight subgroups:the healthy control group,the model group (model established with indomethacin),the teprenone prevention group,the rabeprazole prevention group,the treatment control group,the teprenone treatment group,the rabeprazole treatment group and the teprenone and rabeprazole combined group (combined group),six in each group.Exfoliated cells gap density of small intestine of each subgroup was determined by confocal laser endomicroscopy.Serum level of tumor necrosis factor-α (TNF-α)was measured with enzyme-linked immunosorbent assay (ELISA). The expression of nuclear factor-κB (NF-κB),caspase-3,zonula occludens-1 (ZO-1 )and occludin at protein level was detected by Western blotting.The LSD-t test or Hamhane′s T2 test was performed for statistical analysis.Results The exfoliated cells gap densities of the teprenone prevention group and the rabeprazole prevention group were (57.43 ± 24.55 )/1 000 and (59.80 ± 21 .14 )/1 000,respectively, which were both lower than that of the model group ((110.93±50.58)/1 000),and the differences were statistically significant (t= 53.50 and 54.13,both P < 0.01 ).The exfoliated cells gap density of the combined group was (40.53 ±15 .39)/1 000,which was lower than that of the treatment control group ((93.80±40.65 )/1 000 ),and the difference was statistically significant (t =44.27,P <0.01 ).The serum levels of TNF-α of the teprenone prevention group and the rabeprazole prevention group were (25 .80±8.97)ng/L and (22.74 ±7.15 )ng/L,repsectively,which were both lower than that of the model group ((44.48 ± 7.42 )ng/L),and the differences were statistically significant (t = 18.68 and 21 .74,both P <0.01 ).The serum level of TNF-αof the combined group ((13.66 ±4.98)ng/L)was lower than that of the treatment control group ((24.67±6.70)ng/L),and the difference was statistically significant (t = 9.02,P < 0.01 ).The caspase-3 levels of teprenone prevention group and rabeprazole prevention group were 1 .47 ±0.35 and 1 .58 ±0.34,and the NF-κB levels of these two groups were 1 .27±0.14 and 1 .21 ± 0.10,respectively.Compared with those of model group (2.44 ± 0.45 and 1 .69±0.13),the differences were statistically significant (t =0.97,0.86,0.42 and 0.48,respectively, all P <0.01 ).The levels of caspase-3 and NF-κB of the combined group were 0.66±0.06 and 0.44 ± 0.21 ,respectively,which were lower than those of the treatment control group,and the differences were statistically significant (t=0.34 and 0.56,both P <0.01).The expressions of occludin at protein level of the teprenone prevention group and the rabeprazole prevention group were 0.69 ±0.16 and 0.74 ±0.11 , and the levels of ZO-1 were 0.81 ± 0.08 and 0.84 ± 0.12.Compared with those of the model group (0.45 ±0.22 and 0.64±0.07 ),the differences were statistically significant (t =0.24,0.29,0.17 and 0.21 ,respectively,all P <0.01 ).The levels of occludin and ZO-1 of the combined group were 2.50 ± 0.46 and 1 .76±0.18,which were higher than those of the treatment control group,and the differences were statistically significant (t =1 .50 and 0.76,both P <0.01 ).Conclusions The exfoliated cells gap density may be a valuable indicator to predict the degree of inflammation response and permeability of epithelial barrier as well as to evaluate efficacy of medication.Teprenone and rabeprazole have prevention and treatment effects on NSAID-induced injury in rat small intestine.